FLI1 haplodeficiency in MRL/lpr lupus-prone mice was shown to decrease the pathogenicity of T cells by reducing TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid metabolism [47]. Here, FLI1 is linked to systemic lupus erythematosus.